ã¡ãã£ã¢èšäº
èªå®
çé€äžã®æ»è
æ°ãååŽçãææ¡ããŠããªãã
ããºãææ°ããŒã¯ 2,167
twitterã³ã¡ã³ã 1,640ä»¶äž 1ïœ100件
ææ¡ããŠãªãã ãã®å¯èœæ§ãâŠ
ã€ãŸãå ±éãããŠãå
¥é¢ãæãŸããŠèªå®
ã§æ»ãã 人ãã¡ãã³ããæ»è
ã«æ°ããããŠããªã
ãšããããšã
ãšããããšã
æ»è
æ°ç°åžžã«å°ãªãã®åã«ææ¡ã§ããŠãªãã ãã ãã³ã¬
èªå®
çé€ãåºæ¬ãšããšãã§ããªãåºæºäœã£ãŠãããŠãææ¡ããŠãªãã£ãŠããããã ãð¢
ãèªå®
çé€äžã«æ»äº¡ãã人ã®äººæ°ã«ã€ããŠãæ¿åºåŽã«å°ããããååŽçã¯ãææ¡ããŠããªãããšè¿°ã¹ããã
ãããããããŸã ãŸã ãããããã
ã²ã©ãæ¿åºã
ãããããããŸã ãŸã ãããããã
ã²ã©ãæ¿åºã
ããããšãããããŸããããããæ¹ãããããã²ãé¡ãããããšæã£ãŠããããšããããŸãããæ£ç¢ºãªæ»è
æ°ããããããã«ååŽçã«åããããŠãã ããã
æ£çŽâŠããã£ãŠéåžžã«æãããäºãããªãã§ããð±âïž
èªå® çé€äžã®æ»è æ°ã¯ãéèšåºæ¥ãŠããªãã®ã§ã«ãŠã³ãããŠããªãâŠã«ãŠã³ãããŠããªããšèšãäºã¯ãæ¥ã ã®æ»è æ°ãšããŠçºè¡šãããªãâŠ
èŠããã«âŠèªå® çé€äžã«äœå亡ããªã£ãŠããã®ããå šãææ¡åºæ¥ãŠããªãâŠãšèšãäºð°
èªå® çé€äžã®æ»è æ°ã¯ãéèšåºæ¥ãŠããªãã®ã§ã«ãŠã³ãããŠããªãâŠã«ãŠã³ãããŠããªããšèšãäºã¯ãæ¥ã ã®æ»è æ°ãšããŠçºè¡šãããªãâŠ
èŠããã«âŠèªå® çé€äžã«äœå亡ããªã£ãŠããã®ããå šãææ¡åºæ¥ãŠããªãâŠãšèšãäºð°
# Yahooãã¥ãŒã¹
ã©ããã§å»ç厩å£ããŠããã®ã«æ»è
æ°ãå°ãªãããã ããååŽçãææ¡ããŠãªãã£ãŠã¡ãã£ãšããããæ¥æ¬ã§ã¯ç
é¢ä»¥å€ã§æ»ãã°èŠå¯ãçŸå Žã«è¡ããããã§ç¶æ³èãã°åãããšæããã ãã©ã
ãªããèªå®
çé€ã®æ»äº¡è
æ°ã¯æ¿åºãææ¡ã§ãã
ææ¡ããŠããªãã¿ããã§ããã
èªå® çé€äžã®æ»äº¡è æ°ã
ãããªãã§éçè æ°ãæ»äº¡è æ°ãçºè¡šãããŠãããã
èªå® çé€äžã®æ»äº¡è æ°ã
ãããªãã§éçè æ°ãæ»äº¡è æ°ãçºè¡šãããŠãããã
ã»ããšã ã£ãã
8æ10æ¥ ææ¥èšäº
éå ã®ã³ãã察çæ¬éšãšååŽéšäŒã®ååéšäŒã§ååŽçã説æ
ç§èŠïŒæ¥æ¬ã®æ»äº¡è æ°ããã®æäœãããçããåããŠããã
éå ã®ã³ãã察çæ¬éšãšååŽéšäŒã®ååéšäŒã§ååŽçã説æ
ç§èŠïŒæ¥æ¬ã®æ»äº¡è æ°ããã®æäœãããçããåããŠããã
èªå®
çé€è
ã10äžäººã«è¿«ã ç
åºã®ã¹ããŒãž4ã¯28éœåºç
èªå® çé€äžã®æ»è æ°ãååŽç ææ¡ããŠããªã
ãã®2ã€ã®ãã¥ãŒã¹ã®çµ¶æã³ã³ãæã
èªå® çé€äžã®æ»è æ°ãååŽç ææ¡ããŠããªã
ãã®2ã€ã®ãã¥ãŒã¹ã®çµ¶æã³ã³ãæã
èªå®
çé€äžã®æ»è
æ°ååŽçãææ¡ããŠããªãã
ç°æååŽçžã
ãèºççç¶ã®ãã人ã¯ãååå ¥é¢ã
ãšçåŒããç¹ã«ã€ããŠãæ¹ééãã«
æ£è ãå ¥é¢ã§ããŠããã®ãïŒ
ååŽçã¯
ããããã ããšçããããææãæã¡åãããŠããªãã
ãïœïœäœèšã£ãŠãã®ïŒð±
ç°æååŽçžã
ãèºççç¶ã®ãã人ã¯ãååå ¥é¢ã
ãšçåŒããç¹ã«ã€ããŠãæ¹ééãã«
æ£è ãå ¥é¢ã§ããŠããã®ãïŒ
ååŽçã¯
ããããã ããšçããããææãæã¡åãããŠããªãã
ãïœïœäœèšã£ãŠãã®ïŒð±
ãç«æ²ã®é·åŠ»æååŽéšäŒé·ã¯ãæ±äº¬äºèŒªã®ã¡ãã£ã¢é¢ä¿è
åãã«åãããã150æ£ã®æ°éããã«ã«ã€ããŠãã空宀ã«ãªãå¯èœæ§ãããããã«ãçé€æœèšã«è»¢çšããŠã»ããããšèŠæãããå
é£å®æ¿ã®ãªãªãã©äºåå±ã¯ãçµç¹å§å¡äŒãæ±äº¬éœãšæ©æ¥ã«äœå¶ãèãããããšå¿ãããã
ãããªèšäºãã
æ»è
æ¥æžã®æ¥æ¬ãã©ããªããªãªã³ããã¯ä»¥éãäžçãšã®æ¯èŒã§æ£ããæãã
åèèšäº
ç»åã¯ç¬¬4æ³¢ã®å€§éªãå®éã«ãã®ããã«äžèªç¶ãªããŒã¿ãåºãŠããã
åèèšäº
ç»åã¯ç¬¬4æ³¢ã®å€§éªãå®éã«ãã®ããã«äžèªç¶ãªããŒã¿ãåºãŠããã
8æ10æ¥ã®èšäºã§ãããæ¯æ¥çºè¡šãããç ç²è
ã®æ¹ã
ã®æ°ã«ã¯èªå®
çé€äžã®å Žåã¯å«ãŸããªããšèšãèªèã§è¯ãã®ã§ãããããæ£ç¢ºãªæ»è
æ°ã¯ã©ããªã£ãŠãããã ïŒ
å®å
šã«åœæ°ãèŠæšãŠãŠãäºã ããã£ãŠãªããã ãã
ææããŠè»œçã§èªå® ã«ããã ãã€éçåããŠæ»ãããããããããªãç¶æ³ã§ãããæãããâŠ
ææããŠè»œçã§èªå® ã«ããã ãã€éçåããŠæ»ãããããããããªãç¶æ³ã§ãããæãããâŠ
ã0.12ïŒ
ãâŠæ°åãèªãäžçã®äžã®æ¥æ¬ã®ã³ãã
ã¯ã¯ãã³æ¥çš®çãäœããŠã ãªãæ»äº¡è ã®å²åãäœãã®ã
åèèšäº
ã¯ã¯ãã³æ¥çš®çãäœããŠã ãªãæ»äº¡è ã®å²åãäœãã®ã
åèèšäº
ãæ±äº¬ã®æææ¡å€§ å¶åŸ¡äžèœãªç¶æ³ãã¢ãã¿ãªã³ã°äŒè°
ã¯ã¯ãã³æ¥çš®çãææ¡ããŠãªããæ±äº¬ãã©ã§çµç¹å§ã
éŠçžã®çºä¿¡ããã¹ãªãŒãããã©éå¬ã¯ãç¡çãéœå»åž«äŒäŒé·
ã¯ã¯ãã³æ¥çš®çãææ¡ããŠãªããæ±äº¬ãã©ã§çµç¹å§ã
éŠçžã®çºä¿¡ããã¹ãªãŒãããã©éå¬ã¯ãç¡çãéœå»åž«äŒäŒé·
é
·ãããððððð
ã人ãåãã°ãŠã£ã«ã¹ãåãã
ã£ãŠ
ç·æ¥äºæ 宣èšäœåãåºããŠãããŠ
åœãŸããã®äººæµãèªãçã¿åºããŠå®å¿å®å šãªäºèŒªâŠïŒ
ãŠèšã£ãåŸãããã
ãïŒã©ããïŒ
ããã«å± ãŠå¹³æ°ãªã®ãâŠ
ã£ãŠ
ç·æ¥äºæ 宣èšäœåãåºããŠãããŠ
åœãŸããã®äººæµãèªãçã¿åºããŠå®å¿å®å šãªäºèŒªâŠïŒ
ãŠèšã£ãåŸãããã
ãïŒã©ããïŒ
ããã«å± ãŠå¹³æ°ãªã®ãâŠ
ãç«æ²ã®é·åŠ»æååŽéšäŒé·ã¯ãæ±äº¬äºèŒªã®ã¡ãã£ã¢é¢ä¿è
åãã«åãããã150æ£ã®æ°éããã«ã«ã€ããŠãã空宀ã«ãªãå¯èœæ§ãããããã«ãçé€æœèšã«è»¢çšããŠã»ããããšèŠæãããå
é£å®æ¿ã®ãªãªãã©äºåå±ã¯ãçµç¹å§å¡äŒãæ±äº¬éœãšæ©æ¥ã«äœå¶ãèãããããšå¿ãããã
è·åæ æ
¢ãçã ãããæ¥æ¬ãå®å
šãªåœãããªããããŒãŒãŒð
ãç«æ²ã®é·åŠ»æååŽéšäŒé·ã¯ãæ±äº¬äºèŒªã®ã¡ãã£ã¢é¢ä¿è
åãã«åãããã150æ£ã®æ°éããã«ã«ã€ããŠãã空宀ã«ãªãå¯èœæ§ãããããã«ãçé€æœèšã«è»¢çšããŠã»ããããšèŠæãããå
é£å®æ¿ã®ãªãªãã©äºåå±ã¯ãçµç¹å§å¡äŒãæ±äº¬éœãšæ©æ¥ã«äœå¶ãèãããããšå¿ãããã
ããã£ãŠãã£ã±ãå°åå察çãªã®ããªïŒ
è«žå€åœã§ã¯ãã€ãã«ã¡ã¯ãã³ããå«ã
COVID-19æ©ææ²»çãããã®ç¡åæäŸãè¡ããæåããŠããŸã
æ¥æ¬ããã€ãã«ã¡ã¯ãã³ããç¹äŸæ¿èªããŸããã
ãã€ãã«ã¡ã¯ãã³ããå«ã
æ©ææ²»çãããã®æäŸããããïŒ
COVID-19æ©ææ²»çãããã®ç¡åæäŸãè¡ããæåããŠããŸã
æ¥æ¬ããã€ãã«ã¡ã¯ãã³ããç¹äŸæ¿èªããŸããã
ãã€ãã«ã¡ã¯ãã³ããå«ã
æ©ææ²»çãããã®æäŸããããïŒ
ãã¡ããå
ã®èšäºã§ããèŠåºãã«éåæããã£ãŠãã¡ãã§åããŸãããããïŒçºèšïŒãšãããªãããã£ã³ãã³ãã¹ãã®èŠåºãã®ã»ããæ£ç¢ºã§ããããã ãšæå³åããå°ãå€ãããŸãã
8æ10æ¥
8æ10æ¥
ããªãã¡ïŒæ¥æ¬åœã¯ïŒæ¢ã«åœå®¶ã®äœãçºããŠããªããšããããšã ïŒ
èªå®
æ»ã®æ¹ã¯
NHKã®HP
æ»è æ°ã«å ¥ããŠããããŠãã®ã ãããããã
ç é¢ã«ããçµ±èšã«ãå ¥ããŠããããªããªããŠäºã«ãªã£ãŠãªããã
NHKã®HP
æ»è æ°ã«å ¥ããŠããããŠãã®ã ãããããã
ç é¢ã«ããçµ±èšã«ãå ¥ããŠããããªããªããŠäºã«ãªã£ãŠãªããã
ããããð¥Ž
å¥åº·ä¿éºæè¿ããŠããã£ãŠã
ããã§ãããïŒ
å¥åº·ä¿éºæè¿ããŠããã£ãŠã
ããã§ãããïŒ
é
·ããªãããã¡ããã¡ãããã
205 ååïŒçªçµã®éäžã§ããã¢ãã£ãµã€ããžã®è»¢èŒã¯çŠæ¢ã§ã (ïŸïŸïœ° MMd6-oq5p)[sage] æçš¿æ¥ïŒ2021/08/17(ç«) 17:26:23.06 ID:vQEIgIPoM [1/2]
>>175
æ¥æ¬ã¯ã³ããã®æ»è æ°ãå šãææ¡ã§ããŠãªãã®ãåçåŽåçãèªããŠã
>>175
æ¥æ¬ã¯ã³ããã®æ»è æ°ãå šãææ¡ã§ããŠãªãã®ãåçåŽåçãèªããŠã
ããããããã¯ãèªå®
çé€ã«ããŠæ»äº¡è
æ°ãããŸããããšããŠãããšããããšãªã®ãïŒ
æ¿åºã¯èªå®
æ»äº¡è
ã®æ°ãææ¡ããŠããªãã
è«žå€åœã§ã¯ãã€ãã«ã¡ã¯ãã³ããå«ã
COVID-19æ©ææ²»çãããã®ç¡åæäŸãè¡ããæåããŠããŸã
æ¥æ¬ããã€ãã«ã¡ã¯ãã³ããç¹äŸæ¿èªããŸããã
ãã€ãã«ã¡ã¯ãã³ããå«ã
æ©ææ²»çãããã®æäŸããããïŒ
COVID-19æ©ææ²»çãããã®ç¡åæäŸãè¡ããæåããŠããŸã
æ¥æ¬ããã€ãã«ã¡ã¯ãã³ããç¹äŸæ¿èªããŸããã
ãã€ãã«ã¡ã¯ãã³ããå«ã
æ©ææ²»çãããã®æäŸããããïŒ
ææ¡ããªããã ããªã
æ¡ã®åŠãæ°åã¯å®æ
ãšæžéããŠãããåããããšã¯å¥ã«ã³ããçŠã®çµæžæ»ã«ã泚ç®ããŠããããã
ãŸãã£ããð±
ããã¯åé¡ã§ãããã
è ç·çã¯è²¬ä»»ãåé¿ããããã«ãèªå® çé€äžã®æ»äº¡è æ°ãææ¡ããªãããã«ããŠããã®ã§ã¯ïŒ
è ç·çã¯è²¬ä»»ãåé¿ããããã«ãèªå® çé€äžã®æ»äº¡è æ°ãææ¡ããªãããã«ããŠããã®ã§ã¯ïŒ
æ»è
æ°ãšéçè
ãå¢ããŠãªãã®ã«äœã§ç·æ¥äºæ
宣èšå»¶é·ãªã®ã£ãŠãã€ãŒãã¡ãã»ããããã©ãããããå
¥é¢ã§ããªããã ããå¢ãããããªãããããååŽçã¯å
¥é¢ããŠã人ã®æ»äº¡ã¯ã«ãŠã³ãããŠããã©èªå®
çé€è
ã¯ããŠãªãããããã
ååŽçããµãããããšâãäºã£ãŠãŸãããïŒã©ããªã£ãã®ã§ãããïŒ
éœã ãã§3äžäººã«åã¶èªå® çé€è ã®æ»äº¡ã確èªãããªããã°ïŒãã®åæ°ãæžã£ãŠïŒã¯ã¯ãã³ã®ãããã§æ»è ãæžããŸããïŒãšã§ãäºãã€ããã§ããããïŒ
ã
éœã ãã§3äžäººã«åã¶èªå® çé€è ã®æ»äº¡ã確èªãããªããã°ïŒãã®åæ°ãæžã£ãŠïŒã¯ã¯ãã³ã®ãããã§æ»è ãæžããŸããïŒãšã§ãäºãã€ããã§ããããïŒ
ã
ãããªç¶æ³ã§ããã©ãªã³ããã¯ããæ°ãªãã ããâŠãããã³ãã察çãããªãã«ãªãããªã
åºç€çŸæ£ãªã30代ç·æ§ èªå®
çé€äžã«å®¹äœæ¥å€ã§æ»äº¡ã
ä»ã«ãããã ãâŠååŽçã¯ææ¡ã«åªããã¹ãã
ä»ã«ãããã ãâŠååŽçã¯ææ¡ã«åªããã¹ãã
ä»åã¯èªå®
çé€è
ã®æ»äº¡æ¡ä»¶ãæãã¿ã«ãªã£ããã©ãååŽçã¯èªå®
çé€ã®æ»äº¡è
æ°ãææ¡ããŠãªãããšèšã£ãŠããããã
æ°·å±±ã®äžè§ã§ã¯ïŒ
æ°·å±±ã®äžè§ã§ã¯ïŒ
ãªãªã³ããã¯ã®é¢ä¿è
ã¯æåã
æã ã¯éåãæ»ã«ããã£ãŠã
æã ã¯éåãæ»ã«ããã£ãŠã
é
·ããª
è«žå€åœã§ã¯ãã€ãã«ã¡ã¯ãã³ããå«ã
COVID-19æ©ææ²»çãããã®ç¡åæäŸãè¡ããæåããŠããŸã
æ¥æ¬ããã€ãã«ã¡ã¯ãã³ããç¹äŸæ¿èªããŸããã
ãã€ãã«ã¡ã¯ãã³ããå«ã
æ©ææ²»çãããã®æäŸããããïŒ
COVID-19æ©ææ²»çãããã®ç¡åæäŸãè¡ããæåããŠããŸã
æ¥æ¬ããã€ãã«ã¡ã¯ãã³ããç¹äŸæ¿èªããŸããã
ãã€ãã«ã¡ã¯ãã³ããå«ã
æ©ææ²»çãããã®æäŸããããïŒ
8æ10æ¥ã®èšäºã ãã©ãçäŒã¿ã§ãããå€ãã£ãŠãªãããã
ãã°ãªãïŒãããªãæ»è æ°ç¥ãããã©ããæèœçåºãšã
ãã°ãªãïŒãããªãæ»è æ°ç¥ãããã©ããæèœçåºãšã
ãªãã»ã©ãæ¿åºã¯æ
å ±ãæã£ãŠãªãã®ãã
ããŒã¿ã·ã¹ãã ãæ©èœããŠããªãåå ã¯ïŒ
å ¥åè² è·?
ããŒã¿ããŒã¹ã·ã¹ãã ïŒ
ïŒïŒïŒïŒïŒ
å ¥åè² è·?
ããŒã¿ããŒã¹ã·ã¹ãã ïŒ
ïŒïŒïŒïŒïŒ
é
žçŽ æ¿åºŠã®äœäžããæ¬éã§ã¯éã«åããªãäºäŸã
å°æ¹ã¯äžæ®µãšæ°åŒµãããšææ¥ããå ãå°ç
æãã€ããããªãç¶æ³ã§ã¯ãªãã®ã
æè»ã®å°ã¯å µãèªãã
è ãããå°æ± ãããç·æ¥äºæ ã®å¯Ÿå¿ã«åœ±é¿ãåºã¬ããé æ ®ã®ãããéé£ã(ã-ã
èªå® çé€ã®æ»è æ°ãååŽçãææ¡ããŠããªãã
å°æ¹ã¯äžæ®µãšæ°åŒµãããšææ¥ããå ãå°ç
æãã€ããããªãç¶æ³ã§ã¯ãªãã®ã
æè»ã®å°ã¯å µãèªãã
è ãããå°æ± ãããç·æ¥äºæ ã®å¯Ÿå¿ã«åœ±é¿ãåºã¬ããé æ ®ã®ãããéé£ã(ã-ã
èªå® çé€ã®æ»è æ°ãååŽçãææ¡ããŠããªãã
ãªãªã³ããã¯ãšã¯ã¯ãã³æ®åã«ããNOèªç²ããã®ææççºãå»ç厩å£ãããŠæ£è
ã®èªå®
æŸæ£ããã®æ»äº¡
ïŒåŒçšïŒæ°åã³ãããŠã€ã«ã¹ã«ææããèªå®
çé€äžã«æ»äº¡ãã人ã®äººæ°ã«ã€ããŠãæ¿åºåŽã«å°ããããååŽçã¯ãææ¡ããŠããªãããšè¿°ã¹ãã
èªå® åŸ æ©ãåœããŠçœ®ããªãããæ»äº¡è æ°ã®é èœã»æ£æ°ãç¶ããæ¿è ã»å§æ± ãã¢ãã¹ã«äžå³ã«å¯ãããè¡çºã¯å»¶ã ãšç¶ããŸãã
èªå® åŸ æ©ãåœããŠçœ®ããªãããæ»äº¡è æ°ã®é èœã»æ£æ°ãç¶ããæ¿è ã»å§æ± ãã¢ãã¹ã«äžå³ã«å¯ãããè¡çºã¯å»¶ã ãšç¶ããŸãã
è«žå€åœã§ã¯ãã€ãã«ã¡ã¯ãã³ããå«ã
COVID-19æ©ææ²»çãããã®ç¡åæäŸãè¡ããæåããŠããŸã
æ¥æ¬ããã€ãã«ã¡ã¯ãã³ããç¹äŸæ¿èªããŸããã
ãã€ãã«ã¡ã¯ãã³ããå«ã
æ©ææ²»çãããã®æäŸããããïŒ
âŠ
COVID-19æ©ææ²»çãããã®ç¡åæäŸãè¡ããæåããŠããŸã
æ¥æ¬ããã€ãã«ã¡ã¯ãã³ããç¹äŸæ¿èªããŸããã
ãã€ãã«ã¡ã¯ãã³ããå«ã
æ©ææ²»çãããã®æäŸããããïŒ
âŠ
ãã®åœãããããšãããããªã
åçåŽåçã¯ïŒïŒæ¥ ã«ææãèªå®
çé€äžã«æ»äº¡ãã人ã®äººæ°ãææ¡ããŠããããèªæ²»äœåŽã®éèšå
¥åäœæ¥ãé
ããŠããäžã«ãæ¥å¢ããææè
ãžã®å¯Ÿå¿ã«èªæ²»äœãè¿œãããŠããããããããã«é
ããåŸåã«ããããšæããã«ããŸããã
ãããååŽçå»ç³»æå®ãèããæçã倩äžãå
ã®ä¿å¥æã®ä»äºãæžãããæ»è
æ°ãå¢ããå»ç厩å£ãé²ãããšå®åãæ¿æ²»å®¶ã«ã¯ã¡ã·ãŠããªå¯Ÿçã ããªã
ææçæ³ãªã©åºŠå€èŠã§åœæ°ãèŠæ®ºãã«ããè æ¿æš©ã
ææçæ³ãªã©åºŠå€èŠã§åœæ°ãèŠæ®ºãã«ããè æ¿æš©ã
ã€ãŸããæ»ãã§ããïŒïœ£ã£ãŠäºãð€
æ¿åºã®ãèŠæ®ºãäœæŠãéå¬äžã
æ¿åºã®ãèŠæ®ºãäœæŠãéå¬äžã
ææ¡ããŠãªãã£ãŠãïŒéŒ»ïŸïœŒïŸïœ°ïŒ
è«žå€åœã§ã¯ãã€ãã«ã¡ã¯ãã³ããå«ã
COVID-19æ©ææ²»çãããã®ç¡åæäŸãè¡ããæåããŠããŸã
æ¥æ¬ããã€ãã«ã¡ã¯ãã³ããç¹äŸæ¿èªããŸããã
ãã€ãã«ã¡ã¯ãã³ããå«ã
æ©ææ²»çãããã®æäŸããããïŒ
COVID-19æ©ææ²»çãããã®ç¡åæäŸãè¡ããæåããŠããŸã
æ¥æ¬ããã€ãã«ã¡ã¯ãã³ããç¹äŸæ¿èªããŸããã
ãã€ãã«ã¡ã¯ãã³ããå«ã
æ©ææ²»çãããã®æäŸããããïŒ
äžç以äžã¯ ãšèšã£ãŠããããææ¥æ£è
ã®ãããåããªã©ããããå
¥é¢ã§ããªãç¶æ³ã§ããã
ã¯æ¯é¢æ» è£
ã¯æ¯é¢æ» è£
ã€ãŸãèŠæ®ºãã«ããŠããã ã
ã©ãã§ããããšæã£ãŠããšããèããããªãã
ã©ãã§ããããšæã£ãŠããšããèããããªãã
èªå®
çé€è
ã®æ»è
æ°ããããŸãŠïœããã ãšæã£ãã
*ããã㣠⊠8æ10æ¥ä»ã®ææ¥æ°èããã
ããè¡æ¿åºãæ©èœããŠããªã ⊠ããã§ã¯ãç¡æ¿åºç¶æ ã ïŒ
äœãšãããã¿ã©ã¡ãªæ¿æš©ãªãã ãè æ¿æš©ã¯ã
ããè¡æ¿åºãæ©èœããŠããªã ⊠ããã§ã¯ãç¡æ¿åºç¶æ ã ïŒ
äœãšãããã¿ã©ã¡ãªæ¿æš©ãªãã ãè æ¿æš©ã¯ã
ãªããã¢ãã¬ã³ãã飲ãŸããªãã®ãïŒææãããã»ãŒæ»ã¬ããå
ã®èº«äœã«ã¯æ»ããªããšããããšã
ããããã®äºæ
ããªïŒèšäºã¿ã€ãã«ã«æªæãæããã®ã¯ç§ã ãïŒïŒâãææ¡ã§ããŠããªãã±ãŒã¹ãããããããã網çŸ
çã«ã¯ææ¡ããŠããªãããšè¿°ã¹ããèªæ²»äœåŽã«ããéèšã·ã¹ãã ãžã®å
¥åäœæ¥ãé
ããŠãã(以äžç¥ïŒ
> ååŽçæ
åœè
ã¯ãèªå®
çé€ã§ã®æ»è
æ°ã«ã€ããŠãææ¡ã§ããŠããªãã±ãŒã¹ãããããããã網çŸ
çã«ã¯ææ¡ããŠããªãããšè¿°ã¹ãã
ãç«æ²ã®é·åŠ»æååŽéšäŒé·ã¯ãæ±äº¬äºèŒªã®ã¡ãã£ã¢é¢ä¿è
åãã«åãããã150æ£ã®æ°éããã«ã«ã€ããŠãã空宀ã«ãªãå¯èœæ§ãããããã«ãçé€æœèšã«è»¢çšããŠã»ããããšèŠæãããå
é£å®æ¿ã®ãªãªãã©äºåå±ã¯ãçµç¹å§å¡äŒãæ±äº¬éœãšæ©æ¥ã«äœå¶ãèãããããšå¿ãããã â
èªå®
çé€æšé²ã®çç±ã£ãŠã
â ææ¡ã§ããªãç¶æ³ã«ããã
â¡è«žå€åœã®å ±éã«ãã£ããããªãç é¢ã®å»äžãŸã§æ£è ãããšããç é¢èã«ã©ãã«ããªããªãæ»äœãç©ãŸããŠãããã¿ãããªçµµãå ±éã«æŒãããããããªã
ã ã£ãã
â ææ¡ã§ããªãç¶æ³ã«ããã
â¡è«žå€åœã®å ±éã«ãã£ããããªãç é¢ã®å»äžãŸã§æ£è ãããšããç é¢èã«ã©ãã«ããªããªãæ»äœãç©ãŸããŠãããã¿ãããªçµµãå ±éã«æŒãããããããªã
ã ã£ãã
ããã¯éåžžã«é©ãããããçŸå Žã®ææ¡ãããã«å¯Ÿçãªã©æã¡ããããªããæ²»çãæŸæ£ããåœæ°ãæ»äº¡ããŠã確èªããæ°ããªããšåœãå
¬èšããŠããã ãããããªå±æ©ãããã
å
æ¥ååŽçã®ãã®é©ãã®çºèšãçŸç¶ã®ææççºã«ããèªå®
çé€è
ã®æ¥å¢ã§ãäžççã§ãå
¥é¢ã§ããæ¥å€ããããã
èªå® çé€äžã®æ»è æ°æŽã«å¢ããŠããææ¡ã§ããªããç¥ãã¬åãã¬ãéãïŒ
èªå® çé€äžã®æ»è æ°æŽã«å¢ããŠããææ¡ã§ããªããç¥ãã¬åãã¬ãéãïŒ
æé幞ç·ä»£è¡šã¯ãã®æ¥ã®å·è¡åœ¹å¡äŒã§ãåœæå°ã«èšæã®çé€æœèšãäœãã¹ãã ãšææ¡ããã
éå ã¯åã ããææ¡ããŠããŠãããèªæ°å æ¿æš©ã¯æªã ã«ããããšããŠããªã
éå ã¯åã ããææ¡ããŠããŠãããèªæ°å æ¿æš©ã¯æªã ã«ããããšããŠããªã
ç¥äººãã³ããã§èªå®
çé€äžãªãã ãã©ãæ°å®¿åºã®ä¿å¥æã¯å
šç¶é£çµ¡ãªããã»ã£ããããã®ããã
å€å¿ãªã®ã¯ããããã©ããããã®ããšããã°ã©ããªèšãèš³ããã®ïŒ
å€å¿ãªã®ã¯ããããã©ããããã®ããšããã°ã©ããªèšãèš³ããã®ïŒ
æ±äº¬ã®èªå®
çé€è
3äžäººãå±
ãã®ã«1æ¥ã®æ»è
æ°1ã2人ãããã«æããŠãŠåããªãŒã£ãŠæã£ãŠããã©å®ã¯ã«ãŠã³ãããŠãªãã ãã ã£ã話ãã
確ããæ¿åºã¯æ»äº¡è
æ°ãâŠã£ãšèšã£ãŠããã®ã§ã
æç®ããŠç¡ãã®ã§ã¯ãªããå ¥ããŠãªãã ãã
ææ¡ããŠãªãã§æžãŸãã
æç®ããŠç¡ãã®ã§ã¯ãªããå ¥ããŠãªãã ãã
ææ¡ããŠãªãã§æžãŸãã
èªå®
çé€äžã®æ»è
æ°ã
ååŽçãææ¡ããŠããªãã
ååŽçãææ¡ããŠããªãã
èªå®
çé€äžã®æ»äº¡è
ã«ã€ããŠãååŽçã¯ãææ¡ããŠããªãããšããããšã
ã€ãŸãçŸç¶ã§ã¯æ»è ã®å®æ°ã¯çºè¡šå€ããã倧ããããèªå® çé€ããå¢ããã»ã©ã«ææ¡ã§ããªããªã£ãŠãããŸãã
ïŒ8/10 åçåŽåéšäŒïŒ
ã€ãŸãçŸç¶ã§ã¯æ»è ã®å®æ°ã¯çºè¡šå€ããã倧ããããèªå® çé€ããå¢ããã»ã©ã«ææ¡ã§ããªããªã£ãŠãããŸãã
ïŒ8/10 åçåŽåéšäŒïŒ
8/12æ±äº¬éœéœæ§æ£è
ã®ç¶æ³
â¯æ°èŠéœæ§è 4989人
â¯å ¥é¢ç9.7ïŒ å ¥é¢3668人ïŒéœæ§æ£è 37938人
â34270人ã¯ïŒæ²»çãããªãæ£è ïŒ
â 90%以äžã®éœæ§æ£è ãæ²»çãããªãç¶æ³
â ããã¯æ¿åºãšéœã«ãããèŠæ®ºã殺人ã
âçŽã¡ã«å€§èŠæš¡ãªç åºå¢èšã倧èŠæš¡PCRæ€æ»ãšéœæ§è ã®éé¢ã»ä¿è·
â¯æ°èŠéœæ§è 4989人
â¯å ¥é¢ç9.7ïŒ å ¥é¢3668人ïŒéœæ§æ£è 37938人
â34270人ã¯ïŒæ²»çãããªãæ£è ïŒ
â 90%以äžã®éœæ§æ£è ãæ²»çãããªãç¶æ³
â ããã¯æ¿åºãšéœã«ãããèŠæ®ºã殺人ã
âçŽã¡ã«å€§èŠæš¡ãªç åºå¢èšã倧èŠæš¡PCRæ€æ»ãšéœæ§è ã®éé¢ã»ä¿è·
è«žå€åœã§ã¯ãã€ãã«ã¡ã¯ãã³ããå«ã
COVID-19æ©ææ²»çãããã®ç¡åæäŸãè¡ããæåããŠããŸã
æ¥æ¬ããã€ãã«ã¡ã¯ãã³ããç¹äŸæ¿èªããŸããã
ãã€ãã«ã¡ã¯ãã³ããå«ã
æ©ææ²»çãããã®æäŸããããïŒ
COVID-19æ©ææ²»çãããã®ç¡åæäŸãè¡ããæåããŠããŸã
æ¥æ¬ããã€ãã«ã¡ã¯ãã³ããç¹äŸæ¿èªããŸããã
ãã€ãã«ã¡ã¯ãã³ããå«ã
æ©ææ²»çãããã®æäŸããããïŒ
ããããªãæ»è
æ°ãšãåœãŠã«ãªãã®ãïŒ
ããã«ææ¡åºæ¥ãã·ã¹ãã ãªããããäœäººæ»ãã§ããªããŠç¡çã§ããããã
é
·ã話ã ãããã¯æ¬åœã«é
·ãð¢
æ¢ã«1幎å以äžçµã€ã®ã«âïž
çš²ç°æçŸãå£ã«ããéããåœæ°ã®ç掻ãåœã決ããŠ1çªã§ã¯ãªãæ¿æš©ã ããð¢
æ¢ã«1幎å以äžçµã€ã®ã«âïž
çš²ç°æçŸãå£ã«ããéããåœæ°ã®ç掻ãåœã決ããŠ1çªã§ã¯ãªãæ¿æš©ã ããð¢
[æ°åã³ãããŠã€ã«ã¹]
ååŽçæ åœè :èªå® çé€ã§ã亡ããªããªã£ã人æ°ã«ã€ããŠãææ¡ã§ããŠããªãã±ãŒã¹ããããããããç¶²çŸ çã«ã¯ææ¡ããŠããªãã
å»çè·ãšããŠæ¬åœã«ç³ãèš³ãªãæããŸããããããæ¬åœã®ãšããã ãšæããŸãã
(2021/08/10)
ååŽçæ åœè :èªå® çé€ã§ã亡ããªããªã£ã人æ°ã«ã€ããŠãææ¡ã§ããŠããªãã±ãŒã¹ããããããããç¶²çŸ çã«ã¯ææ¡ããŠããªãã
å»çè·ãšããŠæ¬åœã«ç³ãèš³ãªãæããŸããããããæ¬åœã®ãšããã ãšæããŸãã
(2021/08/10)
ææ¡ããŠãªãâŠã§ããªãããã«ãäœãæã£ãŠåœæ°ãå°ãã®ãâŠ
ããããäºåŠæïŒåäŸã®å®å šã¯ïŒïŒïŒ
ãªãªã³ããã¯ã§ã¯æ€æ»ãã³ãã³ããã®ã«åœæ°ã«ã¯ãããæå¥ã®æãŠã«å ¥é¢ããçµãâŠ
ããããäºåŠæïŒåäŸã®å®å šã¯ïŒïŒïŒ
ãªãªã³ããã¯ã§ã¯æ€æ»ãã³ãã³ããã®ã«åœæ°ã«ã¯ãããæå¥ã®æãŠã«å ¥é¢ããçµãâŠ
èªå®
çé€äžã®æ»äº¡è
æ°ã¯ïŒ
âååŽçïŒææ¡ããŠããªãã
ãèºççç¶ã®ãã人ã¯ååå ¥é¢ããšããæ¹ééãã«æ£è ãå ¥é¢ã§ããŠããã®ãã
âååŽçïŒãã§ããŠããããšçããããææããªãã
âååŽçïŒææ¡ããŠããªãã
ãèºççç¶ã®ãã人ã¯ååå ¥é¢ããšããæ¹ééãã«æ£è ãå ¥é¢ã§ããŠããã®ãã
âååŽçïŒãã§ããŠããããšçããããææããªãã
ãªãã§ç«æ²ã«èšããããŸã§ããªãåããªãã®ãããã£ããšããã«ã倧èŠæš¡æœèšã®åãäžãã§ãé²ããŠãèªå®
çé€è
ææžçãããŠãããã°è¯ãã®ã«ã
éèšã·ã¹ãã ãHERâSYSïŒããŒã·ã¹ïŒããžã®å
¥åäœæ¥ãé
ããŠããäžã«ãæ¥å¢ããææè
ãžã®å¯Ÿå¿ã«èªæ²»äœãè¿œãããŠããããããããã«é
ãããšããåŸåã«ããããšããã
ã»ããŸã«æ»
ã³ããïŒ
ããã£ãŠç¡æ¿åºåœå®¶ã ãããã©ãããã«çŽããŠå©æš©ã貪ã瀟äŒïŒéœåã®æªãäºã¯ç¡èŠãç¶ããïŒSARS-CoV-2ã¯SARSã§ã¯ãªããšæãããã£ãŠããæ§ã ããå®æ
ãéœåã®è¯ãæ§ã«è§£éãããç®åºããæ¹ã
ã®å°»æãã¯èª°ã?
èªå® çé€äžã®æ»è æ°ïœ€ååŽçææ¡ããŠããªã digital
èªå® çé€äžã®æ»è æ°ïœ€ååŽçææ¡ããŠããªã digital
åœæ°ã«ç¡é¢å¿ãªåœ
èªå®
çé€ãªã©ããã£ãŠããµãããããã¯èšèéã³ã«éããªãã
家ã§åæã«ã³ããã§æ»ãã äžçŽåœæ°ã¯æ°ããã«å€ããªãããã§ããããããåœãžã£ãã³ã
æ±äº¬ã®ã³ããæ»è
æ°10æ¥2人ã£ãŠãããå°ãªããªãã£ãŠæãããããèŠããâŠ(°âœÂ°)
åçåŽåç èªå® çé€è ã®æ»è æ°ãææ¡ããŠãªãã ãšâïž
åçåŽåç èªå® çé€è ã®æ»è æ°ãææ¡ããŠãªãã ãšâïž
èªå®
åŸ
æ©ãçºçããæç¹ã§ãã³ããç±æ¥ã®æ»è
æ°ãã«ãŠã³ãã§ããªãããããã³ããã«é¢ããŠã¯æ«ææŠã«çªå
¥ããŠããã
å
é£ç·èŸè·ããã£ð¢
ç«æ²ã®é·åŠ»æååŽéšäŒé·ã¯ãæ±äº¬äºèŒªã®ã¡ãã£ã¢é¢ä¿è
åãã«åãããã150æ£ã®æ°éããã«ã«ã€ããŠãã空宀ã«ãªãå¯èœæ§ãããããã«ãçé€æœèšã«è»¢çšããŠã»ããããšèŠæãããå
é£å®æ¿ã®ãªãªãã©äºåå±ã¯ãçµç¹å§å¡äŒãæ±äº¬éœãšæ©æ¥ã«äœå¶ãèãããããšå¿ãããã â
ãç«æ²ã®é·åŠ»æååŽéšäŒé·ã¯ãæ±äº¬äºèŒªã®ã¡ãã£ã¢é¢ä¿è
åãã«åãããã150æ£ã®æ°éããã«ã«ã€ããŠãã空宀ã«ãªãå¯èœæ§ãããããã«ãçé€æœèšã«è»¢çšããŠã»ããããšèŠæãããå
é£å®æ¿ã®ãªãªãã©äºåå±ã¯ãçµç¹å§å¡äŒãæ±äº¬éœãšæ©æ¥ã«äœå¶ãèãããããšå¿ãããã
å㞠次ãž